Clinical trial awareness, attitudes, and participation among patients with cancer and oncologists

Community Oncology

Volumn 6, Issue 5, 2009, Pages

  Fenton, Laurie ^a   Rigney, Maureen ^a   Herbst, Roy S ^b  

^a Lung Cancer Alliance   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; CANCER PATIENT; CANCER RESEARCH; CLINICAL TRIAL; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; HEALTH SURVEY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATICS; MEDICAL SPECIALIST; PATIENT ATTITUDE; PATIENT PARTICIPATION; PATIENT REFERRAL; PHYSICIAN ATTITUDE;

EID: 66549085254     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1548-5315(11)70546-0     Document Type: Article

References (18)

1. Paskett ED, Cooper MR, Stark N, et al. Clinical trial enrollment of rural patients with cancer. Cancer Pract 2002;10:28-35.
2. Lara PN Jr, Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 2001;19:1728-1733.
3. Wright JR, Crooks D, Ellis PM, Mings D, Whelan TJ. Factors that influence the recruitment of patients to phase III studies in oncology: the perspective of the clinical research associate. Cancer 2002;95:1584-1591.
4. Tournoux C, Katsahian S, Chevret S, Levy V. Factors influencing inclusion of patients with malignancies in clinical trials. Cancer 2006;106:258-270.
5. Cohen GI. Clinical research by community oncologists. CA Cancer J Clin 2003;53:73-81.
6. Demmy TL, Yasko JM, Collyar DE, et al. Managing accrual in cooperative group clinical trials. J Clin Oncol 2004;22:2997-3002.
7. Mannel RS, Walker JL, Gould N, et al. Impact of individual physicians on enrollment of patients into clinical trials. Am J Clin Oncol 2003;26:171-173.
8. American Cancer Society. Cancer Facts & Figures 2008. www.cancer.org/docroot/STT/content/STT-1x-Cancer-Facts-and- Figures-2008.asp? from=fast. Accessed May 5, 2009.
9. National Comprehensive Cancer Network. Non-Small Cell Lung Cancer. NCCN Clinical Practice Guidelines in Oncology - v.2.2009. www.nccn.org/professionals/ physician-gls/PDF/nscl.pdf. Accessed May 5, 2009.
10. Ellis PM. Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol 2000;11:939-945.
11. Kaas R, Hart AAM, Rutgers EJT. The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer. Breast 2005;14:310-316.
12. Benson AB III, Pregler JP, Bean JA, Rademaker AW, Eshler B, Anderson K. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. J Clin Oncol 1991;9:2067-2075.
13. Corrie P, Shaw J, Harris R. Rate limiting factors in recruitment of patients to clinical trials in cancer research: descriptive study. BMJ 2003;327:320-321.
14. Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E. Public attitudes toward participation in cancer clinical trials. J Clin Oncol 2003;21:830-835.
15. Go RS, Frisby KA, Lee JA, et al. Clinical trial accrual among new cancer patients at a community-based cancer center. Cancer 2006;106:426-433.
16. Embi PJ, Jain A, Clark J, Bizjack S, Hornung R, Harris CM. Effect of a clinical trial alert system on physician participation in trial recruitment. Arch Intern Med 2005;165:2272-2277.
17. Venook AP, Blanke CD, Goldberg RM, et al. Assessing the combination of FOLFOX and FOLFIRI with bevacizumab, cetuximab, or both in metastatic colorectal cancer. Commun Oncol 2006;3:593-598.
18. Barrett R. A nurse's primer on recruiting participants for clinical trials. Oncol Nurs